General medicines
Product information:
- Sotrovimab for Injection product monograph (PDF - 290 KB)
Patient information:
- Important information (PDF - 103 KB) for patients
Health Product Risk Communications:
- 22 September 2021 - Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic (PDF - 510 KB)
- 14 April 2022 - Important Safety Information on Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant (PDF - 581 KB)
